Depression screening by nurses in people on long-term kidney dialysis
Official title: Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients
Run by Centre Hospitalier Annecy Genevois · NCT07651436 · Data updated 2026-11-12
This study tests how well nurses can screen for depressive symptoms in people receiving chronic hemodialysis to see if it helps identify those in need of support.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 450 (estimated) |
| Sponsor | Centre Hospitalier Annecy Genevois Academic / other |
| Locations | 2 sites (Annecy and 1 other locations) |
| Status | Recruiting |
| Started | June 26, 2026 |
| Main results expected | June 2028 |
| Study ends | October 2028 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07651436 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults on conventional hemodialysis for at least 3 months, fluent in French, and able to consent.
✕Probably not a fit
Patients with dementia, language barriers preventing self-assessment, or those not at risk for depression may see no direct benefit from this screening approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates the performance of nurse-administered, hetero-assessed depression screening methods in adults undergoing conventional hemodialysis for at least three months. The goal is to compare different modalities used by nurses to detect depressive symptoms, with the aim of improving early identification and management. The study is conducted in French-speaking centers and involves patients who are on a three-times-weekly dialysis schedule and able to provide consent. Exclusion criteria include dementia, pregnancy, language barriers hindering self-assessment, and current participation in another interventional trial. The overall focus is on whether nurse-led screening can better capture depressive symptoms and potentially influence patient outcomes in this population.
Why it matters
Potential benefit: If successful, the approach could improve early detection of depression among dialysis patients and prompt timely support and treatment.
How similar studies have gone: Previous studies have explored nurse-led or hetero-assessed screenings in chronic disease care, showing potential benefits in detection, though results vary by setting and method.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient informed about the nature, process, and objectives of the study and having signed a free and informed consent to participate, * Patient treated with conventional hemodialysis for at least 3 months and currently undergoing dialysis 3 times a week, * Patient covered by the french national social welfare Exclusion Criteria: * Patient suffering from dementia * Pregnant or breastfeeding patient * Patient unable to understand the French language both orally and in writing, - making self-assessment impossible * Patient currently participating in another interventional research protocol or in an exclusion period from such research * Patient who has already been included in this study * Patient under guardianship, curatorship, or placed under judicial protection.
Where it's running
-
Centre Hospitalier Annecy Genevois
Annecy, France Recruiting -
Centre Hospitalier Métropole Savoie
Chambéry, France Not yet recruiting
Study contacts
- Principal investigator: Cécile Herlet — Centre Hospitalier Annecy Genevois
- Study coordinator: Alexandra Rippoz
- Email: arippoz@ch-annecygenevois.fr
- Phone: 0033 4 85522120
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Step-by-step care plan to improve treatment for moderate depression in general practice
It tests whether a structured step-by-step care plan used by general practitioners works better than usual GP care or psychologist-led behavioral therapy for adults 18–65 with moderate depression.
-
Creating Health online course for people with rheumatological conditions
This project will test whether an online course about diet and self-care helps adults with rheumatoid arthritis, Sjogren's syndrome, lupus, mixed connective tissue disease, or psoriatic arthritis reduce fatigue and improve quality of life.
-
Ultra-brief digital help while waiting for psychotherapy
This trial tests different versions of a short online program (UKADO) to help adults with depression or anxiety who are waiting for outpatient psychotherapy.
-
EGR2 and NLRP3 pathways in sleep apnea-related thinking and mood problems
This study will test whether activity in the EGR2 and NLRP3 inflammation pathways is linked to thinking, memory, and mood problems in children and adults with obstructive sleep apnea compared with healthy volunteers.
-
Internet-based cognitive behavior therapy for alcohol use and mental illness
This study is testing if an online therapy program can help adults with both alcohol problems and mild to moderate mental health issues feel better and drink less.
-
Blended (online + in-person) versus face-to-face transdiagnostic group therapy for anxiety and depression
This trial will try whether a blended program (online modules plus group sessions) helps adults with anxiety or depression as much as traditional face-to-face group therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.